Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Digital health company, 1st Group has completed a $2.6 million placement
  • This will see the company launch SPP enabling eligible shareholders to increase holding by up to $15,000
  • Funds raised under the Placement and SPP will be used to support further growth, additional sales and marketing capability, working capital requirements and technology development

Digital health company, 1st Group Limited has announced obtaining commitments from institutional, sophisticated and professional investors for a placement of 65,362,500 fully paid ordinary shares. The placement will raise approximately $2.6 million before costs.

Ist Group has also announced the launch of a Share Purchase Plan, enabling shareholders of the Company to apply for new paid ordinary shares at an issue price of $0.04 per SPP Share, to increase its holding by up to $15,000. The SPP will not be underwritten.

This is an exciting time for 1st Group as funds raised under the placement and SPP will be used to support further growth, additional sales and marketing capability, working capital requirements and technology development – specifically that of its digital platforms: MyHealth1st, PetYeti.com and GoBookings.com.

CEO Klaus Bartosch stated, “I am delighted with the strong support shown by current and new investors for 1st Group. We have significant momentum reflected in our recent announcements and look forward to those investors joining us on this exciting journey.”

The SPP is scheduled to open on 20 May 2019 along with the dispatch of the SPP Offer Booklet. The SPP will close on 10 June 2019.

Read and comment on the full announcement

1ST by the numbers
More From The Market Herald
Dimerix (ASX:DXB) - Managing Director and CEO, Nina Webster

" Dimerix (ASX:DXB) expands DMX-200 study into Australia

Dimerix (DXB) has entered an agreement with the NHMRC Clinical Trials Centre at the University of Sydney to expand the CLARITY 2.

" ACCC scrambles to halt Virtus Health’s (ASX:VRT) purchase of Healius (ASX:HLS) IVF clinics

The ACCC has taken “a significant step” as it seeks an urgent injunction to stop Virtus Health’s (VRT) proposed acquisition of Adora Fertility
IDT Australia (ASX:IDT) - Chair, Alan Fisher

" IDT Australia (ASX:IDT) signs manufacturing deal with Monash University

IDT Australia (IDT) has entered a master services agreement and services order with Monash University.
Prescient Therapeutics (PTX) - CEO and MD, Steven Yatomi Clarke

" Prescient Therapeutics (ASX:PTX) to present new OmniCAR data at conference

Prescient Therapeutics (PTX) will present new results for its OmniCAR drug at the Cell & Gene Meeting on Mesa in California.